Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases: Evaluation of Therapeutics for MERS-CoV
Shumway, David
Dynport Vaccine Company, LLC, Frederick, MD, United States
Search 14 grants from David Shumway
Search grants from Dynport Vaccine Company, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Prevention Research Center: Category 1 - Center Composite
Design and Characterization on Cigarettes
Paroxetine, Prolonged Exposure, and Biology in Ptsd
Biomedical Research Program at Florida a & M University
CAREER: Quantum Chemistry of Macromolecules
Recently added grants:
Smarter exosomes derived from engineered MSCs promote neo-vascularization
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis
Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
Data and Research Support Center
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201500005I-1-27200003-1
Application #
9430351
Study Section
Project Start
2016-08-23
Project End
2017-04-30
Budget Start
Budget End
Support Year
Fiscal Year
2017
Total Cost
Indirect Cost
Institution
Name
Dynport Vaccine Company, LLC
Department
Type
DUNS #
014130053
City
Frederick
State
MD
Country
United States
Zip Code
21702
Related projects
Comments
Be the first to comment on David Shumway's grant
